NCT03579017 is a clinical trial of ECAS-N in Amyotrophic Lateral Sclerosis, sponsored by Haukeland University Hospital.

Who is sponsoring NCT03579017?

NCT03579017 is sponsored by Haukeland University Hospital.

What drugs are being tested in NCT03579017?

Interventions in NCT03579017: ECAS-N, MoCA.

What condition does NCT03579017 study?

NCT03579017 studies Amyotrophic Lateral Sclerosis, Cognitive Impairment.

Is NCT03579017 still recruiting?

NCT03579017 is currently completed. Last updated 30 October 2024.

Last reviewed 2024-10-30 · How we verify

NCT03579017

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Validation Study

Completed Last updated 30 October 2024

What this trial tests

trial testing ECAS-N in Amyotrophic Lateral Sclerosis in 31 participants. Completed in 4 May 2023.

Timeline

1 May 2017

Primary endpoint
31 December 2022

4 May 2023

Quick facts

Lead sponsor	Haukeland University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	31
Start date	1 May 2017
Primary completion	31 December 2022
Estimated completion	4 May 2023
Sites	1 location across Norway

Drugs / interventions tested

ECAS-N
MoCA

Conditions studied

Amyotrophic Lateral Sclerosis — all drugs for Amyotrophic Lateral Sclerosis →
Cognitive Impairment — all drugs for Cognitive Impairment →

Sponsor

Haukeland University Hospital

Who can join

Adults 35 to 85, any sex, with Amyotrophic Lateral Sclerosis or Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cognitive impairment is present in about 30-50% of the patients with amyotrophic lateral sclerosis (ALS). Suitable screening tools are available, but none of these are evaluated in a Norwegian population.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Edinburgh Cognitive and Behavioral Amyotrophic Lateral Sclerosis Screen (ECAS) in Norway: Protocol for validation and a prospective cohort study.
Taule T, Spilde Morland A, Arnevik Renså M, Aßmus J, et al · · 2019 · cited 10× · PMID 30976725 · DOI 10.1016/j.conctc.2019.100347
Norwegian version of the Edinburgh cognitive and behavioural ALS screen: Construct validity, internal consistency, inter-rater, and test-retest reliability.
Taule T, Eide IS, Fjær L, Myrberget MA, et al · · 2023 · cited 1× · PMID 37141321 · DOI 10.1371/journal.pone.0285307

Verify or expand the search:

Other trials of ECAS-N

Trials testing the same drug.

NCT03578796 — Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Prospective Cohort Study · active not recruiting

Other recruiting trials for Amyotrophic Lateral Sclerosis

Currently open trials in the same condition.

NCT07502677 — Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Scle · recruiting
NCT07478172 — Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease · NA · recruiting
NCT07204977 — Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS) · Phase 1 · active not recruiting
NCT07290062 — A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants · Phase 1 · recruiting
NCT07259980 — A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD- · recruiting

Other Haukeland University Hospital trials

Trials by the same sponsor.

NCT07450105 — Intensive Dialectical Behavior Therapy for Self-Harm and Suicidal Behavior in Youth: A Pilot Study · NA · not yet recruiting
NCT07450092 — Prehospital Use of Forced Air Warming · NA · enrolling by invitation
NCT07268716 — Assess the Efficacy of Tailored Patient Information and Voluntary Patient-managed Outpatient Digital Follow-up (I-POD) a · NA · not yet recruiting
NCT07392697 — The Intravenous Amino Acid Therapy for Vascular Rigidity in End Stage Renal Disease · NA · not yet recruiting
NCT07304219 — Physical Activity Based Treatment for Youth With Depression and Anxiety · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03579017 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Haukeland University Hospital
Last refreshed: 30 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03579017.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing